查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522228

2024 年 IVD 酵素全球市场报告

In Vitro Diagnostics Enzymes Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

由于癌症发病率上升，IVD 酶市场预计将显着增长。癌症是一组以异常细胞生长和分裂为特征的疾病，对健康组织构成威胁。导致癌症盛行率增加的因素包括感染疾病、免疫系统功能障碍和荷尔蒙影响。 IVD 酶在癌症医学的各种诊断和监测分析中发挥着重要作用，从癌症的早期检测和诊断到治疗方法选择、监测和个人化医疗。例如，世界卫生组织 (WHO) 预测，到 2050 年，新发癌症病例将比 2022 年增加 77%，这增加了癌症管理中对 IVD 酶的需求。

IVD 酵素市场的主要企业正在投资自体免疫疾病检测套件等创新产品，以维持其市场地位。这些套件旨在检测免疫系统错误攻击身体组织的自体免疫疾病。例如，NeoDx Biotech Labs Pvt Ltd.最近推出了一款用于自体免疫疾病检测的IVD套件，该试剂盒融合了免疫测量、分子诊断和抗体检测方法等先进技术。该套件具有较高的敏感度和特异性，使临床医生能够快速且准确地诊断自体免疫疾病。

2023年2月，SD Biosensor Inc.和SJL Partners LLC以15.3亿美元收购了Meridian Bioscience Inc.。此次收购使 SD Biosensor 能够利用 Meridian 在诊断和原材料方面的专业知识，在各种应用中进行免疫学和分子测试。总部位于美国的 Meridian Bioscience Inc. 以其对 IVD 酶和相关技术的贡献而闻名。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 市场促进和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年市场规模表现与成长
  • 市场规模预测与成长，2023-2028，2033F

第六章 市场细分

  • 全球 IVD 酶市场：按酶类型分類的表现和预测，2018-2023、2023-2028F、2033F
  • 蛋白酶
  • 聚合酵素/转录酶
  • 核糖核酸酶
  • 其他的
  • 全球 IVD 酶市场：按疾病类型分類的表现和预测，2018-2023、2023-2028F、2033F
  • 感染疾病
  • 糖尿病
  • 瘤
  • 心臟病
  • 肾
  • 自体免疫疾病
  • 其他的
  • 全球 IVD 酶市场：依技术分类的表现与预测，2018-2023、2023-2028F、2033F
  • 组织学检测
  • 分子诊断
  • 临床化学
  • 其他的
  • 全球 IVD 酶市场：按最终用途分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 製药/生物技术
  • 医院/诊断实验室
  • CRO
  • 学术实验室

第 7 章 区域/国家分析

  • 全球 IVD 酶市场：按地区分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 全球 IVD 酶市场：按国家/地区分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • IVD酵素市场：竞争格局
  • IVD 酵素市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Siemens Healthineers AG

第三十一章 其他重大及创新企业

  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • Grifols SA
  • Hologic Inc.
  • Illumina Inc.
  • Mindray Medical International Limited
  • PerkinElmer Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Promega Corporation
  • Randox Laboratories Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18381

In vitro diagnostics (IVD) enzymes are specialized proteins used in diagnostic tests conducted outside the living organism, typically in a laboratory setting. These enzymes catalyze specific biochemical reactions that help detect, quantify, or monitor the presence of various substances, including pathogens, biomarkers, or other molecules relevant to diagnosing diseases.

The main enzyme types in the in vitro diagnostics enzymes market are proteases, polymerase and transcriptase, ribonuclease, and other enzyme types. Proteases refer to enzymes that catalyze the breakdown of proteins into smaller peptides or amino acids. Various disease types are targeted, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. These enzymes are utilized in various technologies such as histology assays, molecular diagnostics, clinical chemistry, and others, and are used by end users such as pharmaceutical and biotech companies, hospitals and diagnostic labs, contract research organizations (CROs), and academic labs.

The in vitro diagnostics enzymes market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics enzymes market statistics, including in vitro diagnostics enzymes industry global market size, regional shares, competitors with an in vitro diagnostics enzymes market share, detailed in vitro diagnostics enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostics enzymes industry. This in vitro diagnostics enzymes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostics enzymes market size has grown strongly in recent years. It will grow from $1.98 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the increasing incidence of diseases such as cancer and HIV/AIDS, a growing need for diagnostic testing and monitoring of age-related diseases, shifts in lifestyle factors including diet and physical activity, the rise in approval of new diagnostic assays and products by regulatory authorities, and higher healthcare expenditures globally.

The in vitro diagnostics enzymes market size is expected to see strong growth in the next few years. It will grow to $2.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to an increasing focus on personalized healthcare, growing healthcare infrastructure, rising disposable incomes in emerging markets, a rise in collaborations between companies and research institutions, and increasing demand for rapid and convenient diagnostic solutions. Major trends in the forecast period include the adoption of microfluidics technologies, the development of novel enzyme substrates and detection methods, the use of point-of-care molecular diagnostic platforms integrated with enzyme-based amplification techniques, the integration of CRISPR-based technologies with enzyme assays, the use of liquid biopsy techniques, and the utilization of advanced data analytics and bioinformatics tools.

The in vitro diagnostics enzymes market is expected to grow significantly due to the rising prevalence of cancer. Cancer refers to a group of diseases characterized by abnormal cell growth and division, posing a threat to healthy tissues. Factors contributing to the increased prevalence of cancer include infectious agents, immune system dysfunctions, and hormonal influences. In vitro diagnostics (IVD) enzymes play a crucial role in various diagnostic and monitoring assays across the cancer care continuum, from early detection and diagnosis to treatment selection, monitoring, and personalized medicine. For example, the World Health Organization (WHO) projects a 77% increase in new cancer cases by 2050 compared to 2022, highlighting the growing need for in vitro diagnostics enzymes in cancer management.

Leading companies in the in vitro diagnostics enzymes market are investing in innovative products such as autoimmune disorder detection kits to maintain their market position. These kits are designed to detect autoimmune diseases, where the immune system mistakenly attacks the body's tissues. For instance, NeoDx Biotech Labs Pvt Ltd. recently launched an IVD kit for detecting autoimmune disorders, incorporating advanced technologies such as immunoassays, molecular diagnostics, and antibody detection methods. This kit offers high sensitivity and specificity, enabling clinicians to swiftly and accurately diagnose autoimmune conditions.

In February 2023, SD Biosensor Inc. and SJL Partners LLC acquired Meridian Bioscience Inc. for $1.53 billion. This acquisition allows SD Biosensor to leverage Meridian's expertise in diagnostic products and raw materials for immunological and molecular tests across various applications. Meridian Bioscience Inc., based in the US, is known for its contributions to in vitro diagnostic enzymes and related technologies.

Major companies operating in the in vitro diagnostics enzymes market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., Mindray Medical International Limited, PerkinElmer Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin SpA, Promega Corporation, Randox Laboratories Ltd., Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Sekisui Diagnostics LLC, Trivitron Healthcare, Codexis Inc., Amicogen Inc., EKF Diagnostics Holdings plc, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Alpha Laboratories Ltd.

North America was the largest region in the in vitro diagnostics enzymes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) enzymes market consists of revenues earned by entities by providing services such as enzyme engineering, custom enzyme production, validation services, promega custom assay services, and bio-techne enzyme solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro diagnostics (IVD) enzymes market also includes sales of Taq DNA polymerase, reverse transcriptase, alkaline phosphatase (ALP), horseradish peroxidase (HRP), DNA ligase, NEB enzyme products, and sigma-Aldrich diagnostic enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Enzymes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Enzyme Type: Proteases; Polymerase And Transcriptase; Ribonuclease; Other Enzyme Types
  • 2) By Disease Type: Infectious Disease; Diabetes; Oncology; Cardiology; Nephrology; Autoimmune Diseases; Other Disease Types
  • 3) By Technology: Histology Assays; Molecular Diagnostics; Clinical Chemistry; Other Technologies
  • 4) By End Use: Pharma And Biotech; Hospital And Diagnostic Labs; Contract Research Organizations (CROs); Academic Labs
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Enzymes Market Characteristics

3. In Vitro Diagnostics Enzymes Market Trends And Strategies

4. In Vitro Diagnostics Enzymes Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global In Vitro Diagnostics Enzymes Market Size and Growth

  • 5.1. Global In Vitro Diagnostics Enzymes Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global In Vitro Diagnostics Enzymes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global In Vitro Diagnostics Enzymes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. In Vitro Diagnostics Enzymes Market Segmentation

  • 6.1. Global In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proteases
  • Polymerase And Transcriptase
  • Ribonuclease
  • Other Enzyme Types
  • 6.2. Global In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Other Disease Types
  • 6.3. Global In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Histology Assays
  • Molecular Diagnostics
  • Clinical Chemistry
  • Other Technologies
  • 6.4. Global In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharma And Biotech
  • Hospital And Diagnostic Labs
  • Contract Research Organizations (CROs)
  • Academic Labs

7. In Vitro Diagnostics Enzymes Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostics Enzymes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global In Vitro Diagnostics Enzymes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Enzymes Market

  • 8.1. Asia-Pacific In Vitro Diagnostics Enzymes Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China In Vitro Diagnostics Enzymes Market

  • 9.1. China In Vitro Diagnostics Enzymes Market Overview
  • 9.2. China In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India In Vitro Diagnostics Enzymes Market

  • 10.1. India In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan In Vitro Diagnostics Enzymes Market

  • 11.1. Japan In Vitro Diagnostics Enzymes Market Overview
  • 11.2. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia In Vitro Diagnostics Enzymes Market

  • 12.1. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia In Vitro Diagnostics Enzymes Market

  • 13.1. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea In Vitro Diagnostics Enzymes Market

  • 14.1. South Korea In Vitro Diagnostics Enzymes Market Overview
  • 14.2. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe In Vitro Diagnostics Enzymes Market

  • 15.1. Western Europe In Vitro Diagnostics Enzymes Market Overview
  • 15.2. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK In Vitro Diagnostics Enzymes Market

  • 16.1. UK In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany In Vitro Diagnostics Enzymes Market

  • 17.1. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France In Vitro Diagnostics Enzymes Market

  • 18.1. France In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy In Vitro Diagnostics Enzymes Market

  • 19.1. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain In Vitro Diagnostics Enzymes Market

  • 20.1. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe In Vitro Diagnostics Enzymes Market

  • 21.1. Eastern Europe In Vitro Diagnostics Enzymes Market Overview
  • 21.2. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia In Vitro Diagnostics Enzymes Market

  • 22.1. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America In Vitro Diagnostics Enzymes Market

  • 23.1. North America In Vitro Diagnostics Enzymes Market Overview
  • 23.2. North America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA In Vitro Diagnostics Enzymes Market

  • 24.1. USA In Vitro Diagnostics Enzymes Market Overview
  • 24.2. USA In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada In Vitro Diagnostics Enzymes Market

  • 25.1. Canada In Vitro Diagnostics Enzymes Market Overview
  • 25.2. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America In Vitro Diagnostics Enzymes Market

  • 26.1. South America In Vitro Diagnostics Enzymes Market Overview
  • 26.2. South America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil In Vitro Diagnostics Enzymes Market

  • 27.1. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East In Vitro Diagnostics Enzymes Market

  • 28.1. Middle East In Vitro Diagnostics Enzymes Market Overview
  • 28.2. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa In Vitro Diagnostics Enzymes Market

  • 29.1. Africa In Vitro Diagnostics Enzymes Market Overview
  • 29.2. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. In Vitro Diagnostics Enzymes Market Competitive Landscape And Company Profiles

  • 30.1. In Vitro Diagnostics Enzymes Market Competitive Landscape
  • 30.2. In Vitro Diagnostics Enzymes Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. In Vitro Diagnostics Enzymes Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Agilent Technologies Inc.
  • 31.3. Grifols SA
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. PerkinElmer Inc.
  • 31.8. bioMerieux SA
  • 31.9. QuidelOrtho Corporation
  • 31.10. Sysmex Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen N.V.
  • 31.13. DiaSorin SpA
  • 31.14. Promega Corporation
  • 31.15. Randox Laboratories Ltd.

32. Global In Vitro Diagnostics Enzymes Market Competitive Benchmarking

33. Global In Vitro Diagnostics Enzymes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The In Vitro Diagnostics Enzymes Market

35. In Vitro Diagnostics Enzymes Market Future Outlook and Potential Analysis

  • 35.1 In Vitro Diagnostics Enzymes Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 In Vitro Diagnostics Enzymes Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 In Vitro Diagnostics Enzymes Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer